Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Oct 13, 2026

CYTOF — Altamira Therapeutics Ltd. Dilution Risk Tracker

Track CYTOF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CYTOF — Get alerts when the score changes →

As of October 13, 2026, Altamira Therapeutics Ltd. (CYTOF) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Altamira Therapeutics Ltd. has a market capitalization of $289.0K, 4.66M shares outstanding, 2 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.07 below $1 exchange minimum
🔔 Track CYTOF — Get forecast alerts →

Market Data

Market Cap$289.0K
Shares Outstanding4.66M
Float4.12M
Cash$3.8K
Debt$523.9K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore41/100DilutionWatch score record
Shares Outstanding4.66MVerified float table or market cache
Public Float4.12MVerified float table or market cache
Market Cap$289.0KMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

2 institutional holders · 2 shares
#1 LRI Investments, LLC 1 shares
#2 DANSKE BANK A/S 1 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.0K
Days to Cover54.8
% of Float0.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CYTOF Dilution Snapshot

Altamira Therapeutics Ltd. (CYTOF) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CYTOF's DilutionScore has held steady at 41/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202641/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track CYTOF Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CYTOF files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CYTOF — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations